Clinical Trial Update: Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating enzalutamide with gemcitabine and cisplatin in bladder cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Carcinoma Transitional Cell

Drugs mentioned

• CISPLATIN (cisplatin)
• Enzalutamide (enzalutamide)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Bladder Cancer, Carcinoma, Transitional Cell | Phase 1 | Status: COMPLETED | Results posted: 2019-08-01